Pharmacokinetic-pharmacodynamic modeling of QRS-prolongation by flecainide: Heart rate-dependent effects during sinus rhythm in conscious telemetered dogs

被引:6
作者
Sallstrom, Johan [1 ,2 ]
Al-Saffar, Ahmad [1 ,3 ]
Pehrson, Rikard [1 ,4 ]
机构
[1] AstraZeneca R&D, Safety Assessment Sweden, Dept Safety Pharmacol, Sodertalje, Sweden
[2] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden
[3] Uppsala Univ, Dept Med Sci, SE-75185 Uppsala, Sweden
[4] AstraZeneca Res & Dev, Resp & Inflammatory Innovat Med, Dept Drug Metab & Pharmacokinet, Molndal, Sweden
关键词
Nav1.5; QRS; Flecainide; Modeling; Pharmacokinetics; Electrocardiogram; Beagle dog; DRUG-INDUCED PROLONGATION; CHANNEL; QT;
D O I
10.1016/j.vascn.2013.10.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: The duration of the QRS interval is determined by the ion currents involved in cardiac depolarization. Class I antiarrhythmic drugs reduce cardiac excitability and conduction by inhibiting Nav1.5 channels responsible for I-Na, thus increasing the QRS interval. Previous studies in humans as well as in animal models have demonstrated a more pronounced effect on QRS-prolongation during higher heart rates. In the present study, the effects of the Nav1.5 inhibitor flecainide on cardiovascular parameters, were studied in the telemetered beagle dog under normal autonomic control. The heart rate dependency of QRS prolongation was characterized using pharmacokinetic-pharmacodynamic (PKPD) modeling. Methods: Four male telemetered beagle dogs were administered placebo or flecainide (100, 150 and 200 mg) in a Latin square design. The QRS interval and heart rate were recorded, and blood samples were taken. Plasma concentrations of flecainide were fitted to a one compartment oral model and the intrapolated plasma concentrations were fitted to QRS and heart rate data sampled during 5 h after dosing. Results: Flecainide increased the QRS interval in all dogs, whereas there were no effects on heart rate. Using the PKPD model, a statistically significant heart rate-dependent QRS prolongation was linked to individual concentration-time profiles of flecainide. Discussion: PKPD analysis of QRS interval data from unrestrained dogs with sinus rhythm can elucidate mechanisms previously only described during controlled heart rhythm. Specific questions can therefore be addressed in generically designed cardiovascular telemetry safety studies and different types of relationships between parameters can be uncovered. In addition, the present approach can be used to better characterize drug-induced QRS effects in cardiovascular dog models. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:24 / 29
页数:6
相关论文
共 18 条
[1]   INTERACTIONS OF FLECAINIDE WITH GUINEA-PIG CARDIAC SODIUM-CHANNELS - IMPORTANCE OF ACTIVATION UNBLOCKING TO THE VOLTAGE DEPENDENCE OF RECOVERY [J].
ANNO, T ;
HONDEGHEM, LM .
CIRCULATION RESEARCH, 1990, 66 (03) :789-803
[2]  
[Anonymous], 1989, NEW ENGL J MED, V321, P406
[4]   Detecting drug-induced prolongation of the QRS complex: New insights for cardiac safety assessment [J].
Cros, C. ;
Skinner, M. ;
Moors, J. ;
Lainee, P. ;
Valentin, J. P. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2012, 265 (02) :200-208
[5]   Cardiac safety implications of hNav1.5 blockade and a framework for pre-clinical evaluation [J].
Erdemli, Guel ;
Kim, Albert M. ;
Ju, Haisong ;
Springer, Clayton ;
Penland, Robert C. ;
Hoffmann, Peter K. .
FRONTIERS IN PHARMACOLOGY, 2012, 3
[6]   On the relationship between block of the cardiac Na+ channel and drug-induced prolongation of the QRS complex [J].
Harmer, A. R. ;
Valentin, J-P ;
Pollard, C. E. .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (02) :260-273
[7]   Translation of flecainide- and mexiletine-induced cardiac sodium channel inhibition and ventricular conduction slowing from nonclinical models to clinical [J].
Heath, B. M. ;
Cui, Y. ;
Worton, S. ;
Lawton, B. ;
Ward, G. ;
Ballini, E. ;
Doe, C. P. A. ;
Ellis, C. ;
Patel, B. A. ;
McMahon, N. C. .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2011, 63 (03) :258-268
[8]   Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction [J].
Lund, Lars H. ;
Jurga, Juliane ;
Edner, Magnus ;
Benson, Lina ;
Dahlstrom, Ulf ;
Linde, Cecilia ;
Alehagen, Urban .
EUROPEAN HEART JOURNAL, 2013, 34 (07) :529-539
[9]   Subject-specific heart rate dependency of electrocardiographic QT, PQ, and QRS intervals [J].
Malik, Marek ;
Hnatkova, Katerina ;
Sisakova, Martina ;
Schmidt, Georg .
JOURNAL OF ELECTROCARDIOLOGY, 2008, 41 (06) :491-497
[10]  
Ollerstam Anna, 2007, Journal of Pharmacological and Toxicological Methods, V55, P35, DOI 10.1016/j.vascn.2006.02.009